List of references sorted by page name. Is primarily a dump of the 'further reading'.

  * [[beta_blocker_toxicity|Beta blocker toxicity]]
    * [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7595901|Lip GY, Ferner RE.]] Poisoning with anti-hypertensive drugs: beta-adrenoceptor blocker drugs. J Hum Hypertens 1995; 9(4):213-221.
    * [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10866327|Love JN, Howell JM, Litovitz TL, Klein-Schwartz W.]] Acute beta blocker overdose: factors associated with the development of cardiovascular morbidity. J Toxicol Clin Toxicol 2000; 38(3):275-281.
    * [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1967483|Pentel PR, Salerno DM.]] Cardiac drug toxicity: digitalis glycosides and calcium-channel and beta-blocking agents. Med J Aust 1990; 152(2):88-94.
    * [[http://www.ncbi.nlm.nih.gov/sites/entrez|Albertson TE, Dawson A, de Latorre F, Hoffman RS, Hollander JE, Jaeger A, Kerns WR 2nd,Martin TG,Ross MP;American Heart Association;International Liaison Committee on Resuscitation.AnnEmergMed.]]
    * TOX-ACLS: toxicologic-oriented advanced cardiac life support 2001 Apr;37(4 Suppl):S78-90
    * [[http://www.ncbi.nlm.nih.gov/sites/entrez|O'grady J, Anderson S, Pringle D]].//Successful treatment of severe atenolol overdose with calcium chloride.// [[http://javascript.toxicology.wikispaces.net/AL_get%28this%2C%20%27jour%27%2C%20%27CJEM.%27%29%3B|CJEM.]] 2001 Jul;3(3):224-7.
    * Kerns W. Management of beta-adrenergic blocker and calcium channel antagonist toxicity. //Emerg Med Clin North Am//   2007, May;25(2):309-31; abstract viii.

  * [[concept_pharmacokinetics_and_toxicokinetics|Pharmacokinetics]]
    * Evans WE, McLeod HL. Pharmacogenomics Drug disposition, drug targets, and side effects. N Engl J Med 2003;348(6):538-550. {{:wikitox:evans-pharmacogenomics.pdf|PDF}}
    * Martin J, Fay M. Cytochrome P450 drug interactions: are they clinically relevant? Australian Prescriber 2001;24(1):10-12. {{:wikitox:martin-p450druginteractions.pdf|PDF}}
    * Roberts D Buckley N Pharmacokinetic considerations in clinical toxicology: clinical applications. Clin Pharmacokinet. 2007;46(11):897-939. {{:wikitox:roberts-pharmacokintericsinclintox.pdf|PDF}}

  * [[benzodiazepine_toxicity|Benzodiazepine toxicity]]
    * Ahmad Z, Herepath M, Ebden P. Diagnostic utility of flumazenil in coma with suspected poisoning. //BMJ//  1991; 302(6771): 292 [[http://www.ncbi.nlm.nih.gov/pubmed/1998806|PMID1998806]] \\
    * Amrein R1, Hetzel W, Hartmann D, Lorscheid T. Clinical pharmacology of flumazenil. //Eur J Anaesthesio//  1988 ;2 Suppl: 65-80 [[http://www.ncbi.nlm.nih.gov/pubmed/2842143|PMID2842143]] \\
    * Anon. Hypnotic dependence: zolpidem and zopiclone too. //Prescrire Int//  2001; 10(51): 15 [[http://www.ncbi.nlm.nih.gov/pubmed/11503851|PMID11503851]] \\
    * Anon. Zolpidem: now classified as a psychotropic at risk of abuse. //Prescrire Int//  2003; 12(64): 60 [[http://www.ncbi.nlm.nih.gov/pubmed/12674120|PMID12674120]] \\
    * Barrero-Hernandez FJ, Ruiz-Veguilla M, Lopez-Lopez MI, Casado-Torres A. [Epileptic seizures as a sign of abstinence from chronic consumption of zolpidem]. //Rev Neurol//  2002; 34(3): 253–6 [[http://www.ncbi.nlm.nih.gov/pubmed/12022074|PMID12022074]] \\
    * Bramness JG, Arnestad M, Karinen R, Hilberg T. Fatal overdose of zopiclone in an elderly woman with bronchogenic carcinoma. //J Forensic Sci//  2001; 46(5): 1247–9 [[http://www.ncbi.nlm.nih.gov/pubmed/11569575|PMID11569575]] \\
    * Brown MJ, Bristow DR. Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor alpha 1 subunit protein in rat cerebellar granule cells. //Br J Pharmacol//  1996; 118(5): 1103–10 [[http://www.ncbi.nlm.nih.gov/pubmed/8818332|PMID8818332]] \\
    * Buckley NA1, Whyte IM, Dawson AH, McManus PR, Ferguson NW. Self-poisoning in Newcastle, 1987-1992. //Med J Aust//  1995; 162(4): 190-3 [[http://www.ncbi.nlm.nih.gov/pubmed/7877540|PMID7877540]] \\
    * Buckley NA, Whyte IM, Dawson AH, O'Connell D. The relative toxicity of benzodiazepines in overdose. //BMJ//  1995; 310(6974): 219–21 [[http://www.ncbi.nlm.nih.gov/pubmed/7866122|PMID7866122]] \\
    * Burkhart KK, Kulig KW. The diagnostic utility of flumazenil (a benzodiazepine antagonist) in coma of unknown etiology. //Ann Emerg Med//  1990; 19(3): 319–21 [[http://www.ncbi.nlm.nih.gov/pubmed/2106810|PMID2106810]] \\
    * Chern TL, Kwan A. Flumazenil-induced seizure accompanying benzodiazepine and baclofen intoxication. //Am J Emerg Med//  1996; 14(2): 231–2 [[http://www.ncbi.nlm.nih.gov/pubmed/8924153|PMID8924153]] \\
    * Crestani F, Martin JR, Mohler H, Rudolph U. Mechanism of action of the hypnotic zolpidem in vivo. //Br J Pharmacol//  2000; 131(7): 1251–4 [[http://www.ncbi.nlm.nih.gov/pubmed/11090095|PMID11090095]] \\
    * Dassanayake TL, Michie PT, Jones AL, et al. Cognitive skills underlying driving in patients discharged following self-poisoning with central nervous system depressant drugs. //Traffic Inj Prev//  2012 Sep; 13(5): 450–7 [[http://www.ncbi.nlm.nih.gov/pubmed/22931174|PMID22931174]] \\
    * Debailleul G, Khalil FA, Lheureux P. HPLC quantification of zolpidem and prothipendyl in a voluntary intoxication. //J Anal Toxicol//  1991; 15(1): 35–37 [[http://www.ncbi.nlm.nih.gov/pubmed/1675298|PMID1675298]] \\
    * Depoortere H, Zivkovic B, Lloyd KG, et al. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. //J Pharmacol Exp Ther//  1986; 237(2): 649–58 [[http://www.ncbi.nlm.nih.gov/pubmed/2871178|PMID2871178]] \\
    * de Haro L, Valli M, Bourdon JH, et al. Diazepam poisoning with one-month monitoring of diazepam and nordiazepam blood levels. //Vet Hum Toxicol//  2001; 43(3): 174–5 [[http://www.ncbi.nlm.nih.gov/pubmed/11383664|PMID11383664]] \\
    * Derlet RW, Albertson TE. Flumazenil induces seizures and death in mixed cocaine-diazepam intoxications. //Ann Emerg Med//  1994; 23(3): 494–8 [[http://www.ncbi.nlm.nih.gov/pubmed/8135424|PMID8135424]] \\
    * Doble A. New insights into the mechanism of action of hypnotics. //J Psychopharmacol//  1999; 13(4 Suppl 1): S11–S20 [[http://www.ncbi.nlm.nih.gov/pubmed/10667451|PMID10667451]] \\
    * Dollery CT. Therapeutic drugs. CD_ROM DATABASE Release 1.0 ed. London: Churchill Livingstone, 1999 \\
    * Fernandez C, Maradeix V, Gimenez F, Thuillier A, Farinotti R. Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. //Drug Metab Dispos//  1993; 21(6): 1125–8 [[http://www.ncbi.nlm.nih.gov/pubmed/7905394|PMID7905394]] \\
    * Fisher JB, Edgren BE, Mammel MC, Coleman JM. Neonatal apnea associated with maternal clonazepam therapy: a case report. //Obstet Gynecol//  1985; 66(3 Suppl): 34S-35S [[http://www.ncbi.nlm.nih.gov/pubmed/4022513|PMID4022513]] \\
    * Garnier R, Guerault E, Muzard D, et al. Acute zolpidem poisoning–analysis of 344 cases. //J Toxicol Clin Toxicol//  1994; 32(4): 391–404 [[http://www.ncbi.nlm.nih.gov/pubmed/8057398|PMID 8057398]] \\
    * Gaudreault P, Guay J, Thivierge RL, Verdy I. Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment. //Drug Saf//  1991; 6: 247–65 [[http://www.ncbi.nlm.nih.gov/pubmed/1888441|PMID 1888441]] \\
    * Gock SB, Wong SH, Nuwayhid N, et al. Acute zolpidem overdose–report of two cases. //J Anal Toxicol//  1999; 23(6): 559–62 [[http://www.ncbi.nlm.nih.gov/pubmed/10517569|PMID 10517569]] \\
    * Greenblatt DJ, Woo E, Allen MD, Orsulak PJ, Shader RI. Rapid recovery from massive diazepam overdose. //JAMA//  1978; 240(17): 1872–4 [[http://www.ncbi.nlm.nih.gov/pubmed/357765|PMID 357765]] \\
    * Gueye PN, Hoffman JR, Taboulet P, Vicaut E, Baud FJ. Empiric use of flumazenil in comatose patients: limited applicability of criteria to define low risk. //Ann Emerg Med//  1996; 27(6): 730–5 [[http://www.ncbi.nlm.nih.gov/pubmed/8644960|PMID 8644960]] \\
    * Gueye PN, Lofaso F, Borron SW, et al. Mechanism of respiratory insufficiency in pure or mixed drug-induced coma involving benzodiazepines. //J Toxicol Clin Toxicol//  2002; 40(1): 35–47 [[http://www.ncbi.nlm.nih.gov/pubmed/11990203|PMID11990203]] \\
    * Hamad A, Sharma N. Acute zolpidem overdose leading to coma and respiratory failure. //Intensive Care Med//  2001; 27(7): 1239 [[http://www.ncbi.nlm.nih.gov/pubmed/11534578|PMID 11534578]] \\
    * Harry P. [Acute poisoning by new psychotropic drugs.] //Rev Prat//  1997; 47(7): 731–5 [[http://www.ncbi.nlm.nih.gov/pubmed/9183949|PMID 9183949]] \\
    * Haverkos GP, DiSalvo RP, Imhoff TE. Fatal seizures after flumazenil administration in a patient with mixed overdose. //Ann Pharmacother//  1994; 28(12): 1347–9 [[http://www.ncbi.nlm.nih.gov/pubmed/7696723|PMID7696723]] \\
    * Herd B, Clarke F. Complete heart block after flumazenil. //Hum Exp Toxicol//  1991; 10(4): 289 [[http://www.ncbi.nlm.nih.gov/pubmed/1679653|PMID1679653]] \\
    * Hoffman RS, Goldfrank LR. The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail'. //JAMA//  1995; 274(7): 562–9 [[http://www.ncbi.nlm.nih.gov/pubmed/7629986|PMID 7629986]] \\
    * Hojer J, Baehrendtz S, Matell G, Gustafsson LL. Diagnostic utility of flumazenil in coma with suspected poisoning: a double blind, randomised controlled study. //BMJ//  1990; 301(6764): 1308–11 [[http://www.ncbi.nlm.nih.gov/pubmed/1980218|PMID1980218]] \\
    * Ingum J, Bjorklund R, Volden R, Morland J. Development of acute tolerance after oral doses of diazepam and flunitrazepam. //Psychopharmacol//  1994; 113(3–4): 304–10 [[http://www.ncbi.nlm.nih.gov/pubmed/7862837|PMID7862837]] \\
    * Kuitunen T, Mattila MJ, Seppala T. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. //Int Clin Psychopharmacol//  1990; 5 Suppl 2: 115–130 [[http://www.ncbi.nlm.nih.gov/pubmed/2201724|PMID2201724]] \\
    * Kurta DL, Myers LB, Krenzelok EP. Zolpidem (Ambien): a pediatric case series. //J Toxicol Clin Toxicol//  1997; 35(5): 453–7 [[http://www.ncbi.nlm.nih.gov/pubmed/9279301|PMID9279301]] \\
    * Lheureux P, Debailleul G, De Witte O, Askenasi R. Zolpidem intoxication mimicking narcotic overdose: response to flumazenil. //Hum Exp Toxicol//  1990; 9(2): 105–7 [[http://www.ncbi.nlm.nih.gov/pubmed/2111156|PMID2111156]] \\
    * Lheureux P, Vranckx M, Leduc D, Askenasi R. Flumazenil in mixed benzodiazepine/tricyclic antidepressant overdose: a placebo-controlled study in the dog. //Am J Emerg Med//  1992; 10(3): 184–8 [[http://www.ncbi.nlm.nih.gov/pubmed/1586424|PMID1586424]] \\
    * Liappas IA, Malitas PN, Dimopoulos NP, et al. Zolpidem dependence case series: possible neurobiological mechanisms and clinical management. //J Psychopharmacol//  2003; 17(1): 131–5 [[http://www.ncbi.nlm.nih.gov/pubmed/12680751|PMID12680751]] \\
    * Logan BK, Couper FJ. Zolpidem and driving impairment. //J Forensic Sci//  2001; 46(1): 105–10 [[http://www.ncbi.nlm.nih.gov/pubmed/11210892|PMID11210892]] \\
    * Markowitz JS, Brewerton TD. Zolpidem-induced psychosis. //Ann Clin Psychiatry//  1996; 8(2): 89–91 [[http://www.ncbi.nlm.nih.gov/pubmed/8807033|PMID8807033]] \\
    * Meatherall RC. Zopiclone fatality in a hospitalized patient. //J Forensic Sci//  1997; 42(2): 340-3 [[http://www.ncbi.nlm.nih.gov/pubmed/9068198|PMID9068198]] \\
    * Meredith TJ, Jacobsen D, Haines JA, Berger J-C (eds). Naloxone, flumazenil and dantrolene as antidotes. IPCS/CEC evaluation of antidotes series Vol 1. Cambridge University Press, 1993 \\
    * Mordel A, Winkler E, Almog S, Tirosh M, Ezra D. Seizures after flumazenil administration in a case of combined benzodiazepine and tricyclic antidepressant overdose. //Crit Care Med//  1992; 20(12): 1733–4 [[http://www.ncbi.nlm.nih.gov/pubmed/1458953|PMID1458953]] \\
    * Patat A, Naef MM, van Gessel E, Forster A, Dubruc C, Rosenzweig P. Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic. //Clin Pharmacol Ther//  1994; 56(4): 430–6 [[http://www.ncbi.nlm.nih.gov/pubmed/7955804|PMID7955804]] \\
    * Pounder DJ, Davies JI. Zopiclone poisoning: tissue distribution and potential for postmortem diffusion. //Forensic Sci Int//  1994; 65(3): 177–83 [[http://www.ncbi.nlm.nih.gov/pubmed/8039775|PMID8039775]] \\
    * Regouby Y, Delomez G, Tisserant A. [First-degree heart block caused by voluntary zopiclone poisoning]. //Therapie//  1990; 45(2): 162 [[http://www.ncbi.nlm.nih.gov/pubmed/2353332|PMID2353332]] \\
    * Rochette A, Le Niger E, Moulins H, Manchon M. [Voluntary drug poisoning: epidemiology, performance and limits of the emergency laboratory.] //J Toxicol Clin Exp//  1990; 10(6): 395-408 [[http://www.ncbi.nlm.nih.gov/pubmed/2130183|PMID2130183]] \\
    * Royer-Morrot MJ, Rambourg M, Jacob I, Bauer P, Royer RJ. Determination of zopiclone in plasma using column liquid chromatography with ultraviolet detection. //J Chromatogr//  1992; 581(2): 297–9 [[http://www.ncbi.nlm.nih.gov/pubmed/1452623|PMID1452623]] \\
    * Rudolph U, Crestani F, Mohler H. GABA(A) receptor subtypes: dissecting their pharmacological functions. //Trends Pharmacol Sci//  2001; 22(4): 188-94 [[http://www.ncbi.nlm.nih.gov/pubmed/11282419|PMID11282419]] \\
    * Salva P, Costa J. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications. //Clin Pharmacokinet//  1995; 29(3): 142–53 [[http://www.ncbi.nlm.nih.gov/pubmed/8521677|PMID 8521677]] \\
    * Schulze-Bonhage A, Elger CE. Induction of partial epileptic seizures by flumazenil. //Epilepsia//  2000; 41(2): 186–92 [[http://www.ncbi.nlm.nih.gov/pubmed/10691115|PMID10691115]] \\
    * Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. //Br J Psychiatry//  1993; 163: 386–93 [[http://www.ncbi.nlm.nih.gov/pubmed/8104653|PMID8104653]] \\
    * Short TG, Maling T, Galletly DC. Ventricular arrhythmia precipitated by flumazenil. //Br Med J (Clin Res Ed)//  1988; 296(6628): 1070-1 [[http://www.ncbi.nlm.nih.gov/pubmed/3130150|PMID3130150]] \\
    * Velvart J. [Epidemiology of acute drug poisoning in Switzerland.] //Schweiz Med Wochensch//r 1982; 112(31-32): 1101-4 [[http://www.ncbi.nlm.nih.gov/pubmed/7134935|PMID7134935]] \\
    * Weinbroum A, Rudick V, Sorkine P, Fleishon R, Geller E. Long-term intravenous and oral flumazenil treatment of acute diazepam overdose in an older patient. //J Am Geriatr Soc//  1996; 44(6): 737–8 [[http://www.ncbi.nlm.nih.gov/pubmed/8642175|PMID8642175]] \\
    * Wyss PA, Radovanovic D, Meier-Abt PJ. [Acute overdose of Zolpidem (Stilnox).] //Schweiz Med Wochenschr//  1996; 126(18): 750–6 [[http://www.ncbi.nlm.nih.gov/pubmed/8693299|PMID8693299]] \\

  * [[biguanide_toxicity|Biguanide toxicity]]
    * [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6378583&dopt=Abstract|Asmal AC, Marble A. ]]Oral hypoglycemics. An update. //Drugs//  1984; 28: 62-78. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=5472759&dopt=Abstract|Bingle JP. Storey GW. Winter JM. ]]Fatal self-poisoning with phenformin. //Br Med J//  1970; 3: 752. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6691764&dopt=Abstract|Chalopin JM, Tanter Y, Besancenot JF, Cabanne JF, Rifle G. ]]Treatment of metformin-associated lactic acidosis with closed recirculation bicarbonate-buffered haemodialysis. //Arch Int Med//  1984; 144: 203-205. \\ Hardman JG, Gilman AG, Limbird LE. Goodman and Gilman's The pharmacological basis of therapeutics 9th ed. 1996. McGraw Hill, New York. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8853933&dopt=Abstract|Harrower AD. ]]Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency. //Clin Pharmacokinet//  1996; 31(2):111-9. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6345342&dopt=Abstract|Jefferys DB, Volans GN. ]]Self-poisoning in diabetic patients. //Hum Toxicol//  1983; 2:345-348. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=344119&dopt=Abstract|Luft D, Scmulling RM, Eggstein M.]] Lactic acidosis in biguanide treated diabetics. //Diabetologia//  1978; 14:75-87. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1760902&dopt=Abstract|Marchetti P, Giannarelli R, di Carlo A, Navalesi R. ]]Pharmacokinetic optimisation of oral hypoglycaemic therapy. //Clin Pharmacokinet//  1991; 21(4):308-17. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2656043&dopt=Abstract|Marchetti P, Navalesi R.]] Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update. //Clin Pharmacokinet//  1989; 16(2):100-28. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8251683&dopt=Abstract|McGuinness ME, Talbert RL]]. Phenformin induced lactic acidosis: A forgotten adverse drug reaction. //Ann Pharmacother//  1993;27: 1183-87. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9441244&dopt=Abstract|Misbin RI. ]]Phenformin-associated lactic acidosis: Pathogenesis and treatment. //Ann Intern Med//  1977;87: 591-595. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8240727&dopt=Abstract|Moore DF, Wood DF, Volans GN.]] Features, prevention and management of acute overdose due to antidiabetic drugs. //Drug Safety//  1993; 9: 218-229. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6397981&dopt=Abstract|Paterson KR, Paice BJ, Lawson DH. ]]Undesired effects of biguanide therapy. //Adv Drug React Acute Poisoning Rev//  1984; 3(3):173-82. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2833297&dopt=Abstract|Ryder REJ. ]]The danger of high dose sodium bicarbonate in biguanide-induced lactic acidosis: the theory, the practice and alternative therapies. //Br J Clin Pract//  1987;41: 730-737 \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7741982&dopt=Abstract|Scheen AJ, Lefebvre PJ. ]]Antihyperglycaemic agents. Drug interactions of clinical importance. //Drug Safety//  1995; 12(1):32-45. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8743335&dopt=Abstract|Scheen AJ. .]] Clinical pharmacokinetics of metformin. //Clin Pharmacokinet//  1996; 30: 359-371. \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3065405&dopt=Abstract|Seger D. .]] Toxic emergencies of endocrine and metabolic therapeutic agents. //J Emerg Med//  1988; 6(6):527-37 \\ [[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1435883&dopt=Abstract|Stacpoole PW, Wright EC, Baumgartner TG, et al.]] A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. //N Engl J Med//  1992; 327: 1564-9. \\ 6- Dec- 2014